Core Insights - The life sciences industry is undergoing strategic adjustments, with key themes such as "going global," "localization," "frontier tracks," "independent innovation," and "laboratory automation" being discussed at a recent forum [1][2]. Group 1: Industry Challenges and Opportunities - The life sciences instrument industry is facing significant challenges due to the ongoing US-China geopolitical tensions, which have implications for high-end instruments like sequencing devices [2][3]. - The market for life sciences instruments in China is projected to reach nearly $2.4 billion in 2023, with over 42% of demand coming from universities and research institutions, presenting both challenges and opportunities for domestic manufacturers [10]. Group 2: Innovation and Technology Development - Autonomous innovation in high-end life sciences instruments is deemed essential for survival, with companies like Qitan Technology leading the way in developing domestically produced sequencing devices [4][5]. - The development of advanced biosensors is crucial for enhancing the performance of various life sciences instruments, with companies like Liangzhun achieving significant market presence through innovative sensor technology [7]. Group 3: Market Trends and Future Outlook - The future of life sciences is seen in three key areas: new drug development, biobreeding, and organoids, with the market for organoid applications expected to reach $12 billion [10][11]. - The integration of AI and robotics is driving laboratories towards a new 5.0 stage, characterized by fully automated and intelligent systems that enhance experimental efficiency and data management [20][23]. Group 4: Global Expansion Strategies - Companies are encouraged to prioritize product certification and intellectual property protection when expanding into international markets, as demonstrated by Dalong's successful overseas strategy [14][15]. - Agilent's commitment to localization and innovation in China has resulted in over 20% of its global revenue coming from the Chinese market, highlighting the importance of adapting to local needs [18][19].

Core Viewpoint - The forum highlighted the transition from "precision medicine" to the "high-definition medicine" era, emphasizing the integration of AI algorithms and clinical data to enhance diagnostic accuracy and efficiency [4][17]. Group 1: Forum Overview - The "High-definition Medicine and Clinical Diagnosis New Intelligent Technology Forum" was successfully held on May 13, attracting various stakeholders from the precision diagnosis industry [2]. - The forum featured discussions on innovative diagnostic tools and the technical needs of clinical laboratories, fostering in-depth exchanges among participants [2][4]. Group 2: Key Presentations - **Kang Xiong** discussed the evolution of modern medicine, emphasizing the importance of health evaluation throughout the life cycle and the need for dynamic tracking across various exposure groups [8]. - **Song Haibo** highlighted the internationalization of China's in vitro diagnostics (IVD) industry, stressing the importance of comprehensive international layouts, including R&D and logistics [10]. - **Cai Keya** shared insights on the challenges faced by sequencing instruments in hospitals, advocating for targeted innovations to improve product usability and market acceptance [12]. - **Xu Jun** focused on multi-modal medical data analysis, proposing a data-driven approach to enhance disease prevention and treatment through the integration of diverse data sources [14]. - **Zhao Lingxiao** presented advancements in medical 3D visualization and virtual reality technologies, emphasizing the need for improved rendering and interaction in medical applications [16]. Group 3: Industry Trends and Future Directions - The forum concluded with a consensus on the need for collaborative efforts across academia, industry, and research to overcome challenges in the implementation of next-generation diagnostic technologies [17].

导读： 河北省气候中心发布多批政府采购意向，仪器信息网特对其中的仪器设备品目进行梳理，统计出5 项仪器设备采购意向，预算总额达1.44亿元。 特别提示 微信公众号机制调整，请点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无 法看到我们的推送。 近日，河北省气候中心发布5项仪器设备采购意向，预算总额达1 . 4 4亿元，涉及二维成像降水 粒子谱仪、无人机试验平台、冰核采样与分析设备、宽粒径模拟及校准系统、标准粒子发生系 统、气溶胶过滤干燥装置等，预计采购时间为2 0 2 5年6月。 河北省气候中心2 0 2 5年6月仪器设备采购意向汇总表 | 采购 | | 预算 | 采购 | | --- | --- | --- | --- | | | 需求概况 | | | | 项目 | | 万元 | 时间 | | | 采购国家作业飞机（空中国王360HW）1架， | | | | 华北人影项目（河 | 同时加装机载大气探测子系统、机载催化作业 | | | | | 子系统、空地通信子系统及空地综合业务系 | | 2025年 | | 北）——综合作业 | | 10526 | | | 能力建设采购项目 | 统 ...

鉴于美方根据中美经贸高层会谈共识撤销、暂停或调整有关对华加征关税，中方相应调整有关 关税和非关税对美反制措施。 相关阅读： 特别提示 微信公众号机制调整，请点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无 法看到我们的推送。 从商务部获悉，根据美国白宫5月12日发布的《修改对等关税税率以反映与中华人民共和国会 谈情况的行政令》，美方已于美东时间5月14日凌晨00:01撤销根据2025年4月8日第14259 号行政令和2025年4月9日第14266号行政令对中国商品(包括香港特别行政区和澳门特别行 政区商品)加征的共计91%的关税，修改2025年4月2日第14257号行政令对中国商品(包括香 港特别行政区和澳门特别行政区商品)加征的34%的对等关税措施，其中24%的关税暂停加征 90天，保留剩余10%的关税。同时，美方还下调或撤销对中国小额包裹(包括香港特别行政区 小额包裹)加征的关税，将国际邮件从价税率由120%下调至54%，撤销原定于2025年6月1 日起将从量税由每件100美元调增为200美元的措施。 5月14日12时01分起，对美加征关税税率调整为10% 美取消部分加征关税：中 ...

Core Viewpoint - The article highlights the awarding of the "2024 Annual Special Contribution Award for R&D in the Scientific Instrument Industry" to Xu Ying, Chairman of Tianjin Sanying Precision Instrument Co., Ltd., recognizing his significant contributions to the development of high-end scientific instruments in China [1][2]. Group 1: Award Overview - The "China Scientific Instrument Industry R&D Special Contribution Award" was established in 2013 to honor individuals who have made outstanding contributions to scientific instrument technology innovation and industrialization [2][38]. - The award is presented annually at the China Scientific Instrument Development Annual Conference, with a maximum of two recipients each year [2][38]. - The 2025 edition marks the 12th year of the award, with Xu Ying being the 13th recipient [2]. Group 2: Xu Ying's Contributions - Xu Ying, who obtained his PhD from the University of Warwick in 1995, has over 20 years of experience in non-destructive testing and has developed a global perspective through his work in renowned international companies [6]. - He returned to China in 2009 with a mission to contribute to national scientific advancements, leading significant projects such as the development of China's first X-ray three-dimensional microscope with a spatial resolution of 500 nanometers, breaking foreign monopolies [6]. - Under his leadership, Tianjin Sanying Precision Instrument Co., Ltd. has transformed scientific research achievements into internationally advanced products, generating over 850 million yuan in output value and holding 10 invention patents [6]. Group 3: Historical Context of Award Recipients - The article provides a brief overview of past award winners, highlighting their contributions to various fields within scientific instrumentation, such as microwave chemistry, atomic spectroscopy, and the development of advanced analytical instruments [8][10][11][15][18][21][30][33][36]. - Each recipient has played a pivotal role in advancing China's capabilities in scientific instrumentation, often overcoming significant technological challenges and contributing to the country's self-sufficiency in high-tech fields [8][10][11][15][18][21][30][33][36]. Group 4: About the 3i Award - The "3i Award" (Innovative, Interactive, Integrative) was established in 2006 to recognize outstanding contributions in the scientific instrument and testing industry, with a focus on innovation and industry development [39][46]. - The award is based on principles of fairness and transparency, relying on evaluations from industry experts and a large user base to select awardees [39].

导读： 5月9日，由上海复享光学股份有限公司、上海微纳制程智能检测工程技术研究中心主办，Light Publishing Group联合主办的"新时代·新需求·新架构 —— 深度光谱联合创新论坛"启幕。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 新一轮产业革命之际，我国以发展新质生产力为核心战略方向，通过科技创新重构全球产业格局。光感知技术是物理世界深度信息化的基石， 与人工智能深度融合的智能光感知技术将加速赋能新质生产力发展，为半导体、新材料、生物制造等关键领域技术突破提供无限可能。 为深入探讨智能光感知技术发展路径，推动产学研协同创新，本次论坛汇聚顶尖专家学者、产业领袖及技术专家，共同探索智能光感知技术的 应用前景与前沿趋势。 2 0 2 5年5月9日，由上海复享光学股份有限公司（复享光学）、上海微纳制程智能检测工程技术研究中心主办，Li g h t Pu b lis h i n g Gr o u p联合主 办的"新时代·新需求·新架构 —— 深度光谱联合创新论坛"在上海浦东金科园会议中心盛大启幕。 复 享 光 学 新总 部 本次 ...

Core Viewpoint - The 18th China Scientific Instrument Development Annual Conference (ACCSI 2025) was held in Shanghai, focusing on "Digital Intelligence Driven, New Quality Leading" and featuring over 150 reports, attracting more than 1800 participants from various sectors of the scientific instrument industry [1][2]. Group 1: High Spectral and Imaging Technology - The development and application of hyperspectral and imaging technology have made significant progress in China, with the country now ranking among the world's leaders in hyperspectral remote sensing technology [4]. - The Gaofen-5 satellite's wide-band hyperspectral camera, launched in 2018, has achieved a 2% error rate in methane detection, outperforming international standards [4]. - Future advancements will focus on spectral resolution (0.1 nm), spatial resolution (sub-meter level), temporal resolution (dynamic monitoring), and radiation sensitivity (single-photon detection), integrating AI and quantum optics [5]. Group 2: Quantum Technology - The report on quantum computing highlights the need for self-reliance and the importance of scientific instruments in advancing quantum technology [6][7]. - Shenzhen has made notable achievements in quantum research, transitioning from non-existence to being part of the national laboratory system, and has made key breakthroughs in quantum computing [7]. - The report emphasizes the necessity for industry integration and resource consolidation to overcome challenges in innovation and originality [7]. Group 3: Industry Trends and Opportunities - In 2024, the revenue of China's scientific instrument industry reached 108.038 billion yuan, marking a 4.3% year-on-year growth, with significant contributions from domestic brands [11]. - The industry is expected to benefit from national productivity development, the implementation of new policies, and the ongoing US-China trade dynamics [11]. - The report analyzes changes in demand across different fields, user types, and brand preferences, indicating a shift in market dynamics [11]. Group 4: Corporate Strategies - Shimadzu's report outlines its strategic layout and breakthroughs in China, focusing on contributing to human and environmental health through advanced technology [15]. - The company aims to deepen localization efforts and collaborate with top scientific talents and enterprises to drive innovation [15]. - Future focus areas include healthcare, environmental protection, materials, and industrial sectors, aligning with societal needs [15]. Group 5: Domestic Instrument Development - The report discusses the evolution of China's scientific instrument industry over the past 70 years, highlighting the transition from low-end to high-end markets [18]. - Key factors for the growth of domestic scientific instrument companies include talent development, capital focus, and leveraging national policies to enhance competitiveness [18]. - The report concludes with a positive outlook for the future of domestic instruments, emphasizing the importance of innovation and resilience in the industry [18].

Core Viewpoint - Beckman Coulter Life Sciences is celebrating its 90th anniversary in 2025, emphasizing its commitment to innovation and local market development in China, which has become a significant contributor to its global strategy [1][19]. Group 1: Innovation and Historical Development - The company has maintained a focus on solving industry pain points from its inception, starting with the invention of the commercial pH meter in 1935 by Dr. Beckman [3][4]. - The merger of Beckman and Coulter in 1997 expanded the company's technological capabilities across life sciences and clinical diagnostics [4]. - The introduction of the CytoFLEX flow cytometer, developed from local market insights, exemplifies how China serves as both a crucial market and an innovation source [7][9]. Group 2: Localization Strategy - Beckman Coulter Life Sciences has established a comprehensive local value chain in China, including sales, service, manufacturing, and R&D, since the early days of reform and opening up [9][12]. - The Suzhou factory not only serves as a production base but also as a global R&D innovation hub, demonstrating a closed-loop of "China demand driving global innovation" [9][12]. - The company emphasizes that localization does not mean lowering standards but achieving "China manufacturing, global quality" through strict adherence to international quality management systems [12][17]. Group 3: Future Outlook and Ecosystem Development - The company plans to focus on technological foresight and ecosystem collaboration, investing in cutting-edge fields like exosome research and synthetic biology [15][19]. - Beckman Coulter aims to be a trusted partner by providing not only equipment but also training and academic exchanges to elevate industry standards [15][17]. - The balance between globalization and localization is highlighted through increased production capacity in China, which supports both local and global markets [17][19].

Core Viewpoint - Huapu Science and Technology has completed over 100 million yuan in Pre-B round financing, aiming to advance domestic liquid chromatography technology innovation and application, breaking the import monopoly [1][2]. Company Overview - Huapu Science and Technology, established in 2015, has developed a comprehensive product matrix including HPLC (High-Performance Liquid Chromatography), UHPLC (Ultra-High-Performance Liquid Chromatography), and corresponding software and consumables. The company has thousands of its own brand instruments in the mainstream chromatography application market [2][3]. - The company has built a significant competitive advantage in the domestic liquid chromatography field, being one of the few manufacturers capable of entering customs, quality inspection, and drug supervision units, as well as key commercial clients such as pharmaceutical companies and CROs [2]. Market Context - The liquid chromatography market in China is valued at over 10 billion yuan annually, with more than 90% of the market currently dominated by imported brands. The industry is characterized by a high trade deficit, with imports of precision instruments reaching 90.98 billion yuan in 2024, surpassing imports of soybeans and integrated circuits [6][8][9]. - The domestic production of liquid chromatography instruments is not only about the autonomy of life science tools but also about ensuring supply chain security for industrial enterprises, research institutions, and government testing units [9]. Product Development and Innovation - Huapu Science and Technology is continuously expanding its product matrix to achieve platform-scale effects. The company has formed strategic partnerships to promote the domestic production of clinical liquid chromatography and mass spectrometry technology [3][5]. - The company has achieved over 95% localization of core components in its chromatography instruments, ensuring a fully controllable upstream supply chain, which mitigates potential risks from trade disputes [10]. Regulatory Compliance and Software Development - The development of compliant chromatography software is a major bottleneck for domestic liquid chromatography products entering the mainstream market. Huapu has spent eight years developing a fully independent, compliant chromatography control software that meets international regulatory standards [11][12]. - The software is crucial for process control and data storage in drug development and production, serving as an important quality defense for regulatory agencies and large pharmaceutical companies [10]. Customer Engagement and Market Strategy - Huapu Science and Technology has established a comprehensive marketing system that covers market dominance, sales operations, industry solutions, and technical support, enabling rapid response to customer needs [14]. - The company focuses on key growth engines by targeting policy benchmark clients such as customs and drug supervision, as well as commercial benchmark clients like large pharmaceutical companies and CROs, maintaining high business growth over the past three years [14]. Investment and Future Outlook - The recent financing will accelerate the expansion of domestic and international sales channels and enhance the development of next-generation core products. The company aims to integrate cutting-edge technology and innovative concepts to drive industry innovation [15]. - Investors view Huapu as a key player in the domestic liquid chromatography market, emphasizing the importance of its technology and market expansion capabilities in contributing to the development of China's high-end instrument industry [16][17].

特别提示 微信公众号机制调整，请点击顶部"仪 器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 关于批准发布 《家用和类似用途插头插座第31部分：装有USB电源的插座的特殊要求》 等295项推荐性国家标准和2项推荐性国家标准修改单的公告 国家市场监督管理总局（国家标准化管理委员会）批准《家用和类似用途插头插座 第3 1部分：装有USB电源的插座的 特殊要求》等2 9 5项推荐性国家标准和2项推荐性国家标准修改单，现予以公告。 国家市场监督管理总局 国家标准化管理委员会 2 0 2 5年4月2 5日 附件： 关于批准发布《家用和类似用途插头插座第3 1部分：装有USB电源的插座的特殊要求》等2 9 5项推荐性国家标准和2项 推荐性国家标准修改单的公告 (附件).wp s 国家标准公告2 0 2 5年第1 0号-关于批准发布《家用和类似用途插头插座+第3 1部分：装有USB电源的插座的特殊要求》 等2 9 5项推荐性国家标准和2项推荐性国家标准修改单的公告. p d f 点击文末"阅读原文"下载附件 AI大潮袭来，唯有学习方能不被淘汰。 全新升级版 的 AI学习资料包 免费下载：《 ...